http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016184121-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_894889dbe655aa2131f0648dc6218652
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-401
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-09
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-401
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-16
filingDate 2016-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c3f6af318c3d4518ed82a4b54595b5bc
publicationDate 2016-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2016184121-A1
titleOfInvention Naphthalene acetamide compound
abstract A new compound (as shown in formula I) and salts thereof, which are proved to be used for treating and preventing cerebral ischemic diseases and improving sleep by experiments. When R=H, salts are respectively generated by the compound together with alkali metal sodium, magnesium, potassium or calcium and organic alkali tromethamine, diethylamine, triethylamine or the like, and have functions of treating and preventing ischemic cardiovascular and cerebrovascular diseases and improving sleep. Compared with a control group, the present invention is greater in influence on the volume of ischemic cerebral infarction and higher in plasma concentration in brain tissue; and a half-life period is obviously prolonged.
priorityDate 2015-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9321216-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104892725-A

Total number of triples: 18.